全文获取类型
收费全文 | 4401篇 |
免费 | 270篇 |
国内免费 | 19篇 |
专业分类
耳鼻咽喉 | 33篇 |
儿科学 | 147篇 |
妇产科学 | 120篇 |
基础医学 | 611篇 |
口腔科学 | 43篇 |
临床医学 | 585篇 |
内科学 | 787篇 |
皮肤病学 | 65篇 |
神经病学 | 456篇 |
特种医学 | 102篇 |
外科学 | 495篇 |
综合类 | 38篇 |
一般理论 | 3篇 |
预防医学 | 534篇 |
眼科学 | 40篇 |
药学 | 298篇 |
中国医学 | 4篇 |
肿瘤学 | 329篇 |
出版年
2023年 | 48篇 |
2022年 | 27篇 |
2021年 | 155篇 |
2020年 | 103篇 |
2019年 | 130篇 |
2018年 | 137篇 |
2017年 | 86篇 |
2016年 | 109篇 |
2015年 | 114篇 |
2014年 | 172篇 |
2013年 | 242篇 |
2012年 | 358篇 |
2011年 | 414篇 |
2010年 | 192篇 |
2009年 | 198篇 |
2008年 | 302篇 |
2007年 | 323篇 |
2006年 | 301篇 |
2005年 | 241篇 |
2004年 | 251篇 |
2003年 | 207篇 |
2002年 | 177篇 |
2001年 | 28篇 |
2000年 | 21篇 |
1999年 | 26篇 |
1998年 | 27篇 |
1997年 | 29篇 |
1996年 | 20篇 |
1995年 | 24篇 |
1994年 | 21篇 |
1993年 | 19篇 |
1992年 | 15篇 |
1991年 | 12篇 |
1990年 | 20篇 |
1989年 | 10篇 |
1988年 | 12篇 |
1987年 | 11篇 |
1986年 | 8篇 |
1985年 | 11篇 |
1984年 | 7篇 |
1983年 | 6篇 |
1982年 | 9篇 |
1980年 | 4篇 |
1979年 | 5篇 |
1978年 | 7篇 |
1977年 | 5篇 |
1976年 | 7篇 |
1975年 | 6篇 |
1974年 | 4篇 |
1968年 | 4篇 |
排序方式: 共有4690条查询结果,搜索用时 62 毫秒
111.
Clare?E.?Counsilman Cornelia?M.?Jol–van der Zijde Jasper?Stevens Karlien?Cransberg Robbert?G.?M.?Bredius Ram?N.?SukhaiEmail author 《Pediatric nephrology (Berlin, Germany)》2015,30(8):1367-1370
Background
Rituximab (RTX) has recently been introduced as a second-line therapy for nephrotic syndrome in children. Studies show that RTX given during the nephrotic state may be less effective than treatment during a non-nephrotic state, possibly due to loss of RTX in the urine.Case-Diagnosis/Treatment
We describe a 10-year-old boy with steroid-resistant nephrotic syndrome (SRNS) treated with RTX during a phase of active non-selective proteinuria. The serum half-life of RTX in this patient was less than 1 day compared to 20 days in patients without protein losses. Urinary clearance was at least 25 %, compared to approximately 0 % in control patients. However, RTX loss in the urine, as well as in pleural effusion and ascites, only partly explains the rapid drop in the serum RTX concentration of this patient.Conclusions
Serum half-life of RTX can be extremely short, partly due to excessive urinary losses in therapy-resistant nephrotic syndrome with non-selective proteinuria, as seen in our patient. These findings may help to explain the poor results of RTX treatment in patients with active proteinuria.112.
Tarek El-Bialy Adel Alhadlaq Nayef Felemban Jasper Yeung Amal Ebrahim Ali H. Hassan 《The Angle orthodontist》2015,85(2):233
Objective:To evaluate the effect of a light-emitting diode (LED) and/or low-level laser (LLL) with or without the use of anterior bite jumping appliances (also known as functional appliances [FAs]) on mandibular growth in rats.Materials and Methods:Thirty-six 8-week-old male Sprague-Dawley rats weighing 200 g were obtained from Charles River Canada (St. Constant, QC, Canada) and were divided into six groups of six animals each. Groups were as follows: group 1: LLL; group 2: LLL + FA; group 3: LED; group 4: LED + FA; group 5: FA; and group 6: control (no treatment). Mandibular growth was evaluated by histomorphometric and micro computed tomographic (microCT) analyses.Results:The LED and LED + FA groups showed an increase in all condylar tissue parameters compared with other groups.Conclusion:The LED-treated groups showed more mandibular growth stimulation compared with the laser groups. 相似文献
113.
114.
Surprisingly high prevalence of anxiety and depression in chronic breathing disorders 总被引:7,自引:0,他引:7
STUDY OBJECTIVES: The objectives of this study were to assess the prevalence, screening, and recognition of depression and anxiety in persons with chronic breathing disorders, including COPD. DESIGN: Cross-sectional study. SETTING: The Michael E. DeBakey Veterans Affairs Medical Center (MEDVAMC). PARTICIPANTS: A large sample of 1,334 persons with chronic breathing disorder diagnoses who received care at the MEDVAMC. MEASUREMENTS: The prevalence of anxiety and depression was measured in a large sample of persons with a chronic breathing disorder diagnosis who received care at the MEDVAMC, using the Primary Care Evaluation of Mental Disorders (PRIME-MD) screening questions. The positive predictive value of the PRIME-MD questions was then determined. The prevalence of anxiety and depressive diagnoses in patients determined to have COPD was then measured, using the Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (SCID). RESULTS: Of patients screened with the PRIME-MD, 80% screened positive for depression, anxiety, or both. The predictive value of a positive phone screen for either depression or anxiety was estimated to be 80%. In the subsample of patients who had COPD and received a diagnosis using the SCID, 65% received an anxiety and/or depressive disorder diagnosis. Of those patients, only 31% were receiving treatment for depression and/or anxiety. CONCLUSIONS: It is troubling that a mere 31% of COPD patients with depression or anxiety are being treated, particularly given their high prevalence in this population. Practical screening instruments may help increase the recognition of anxiety and depression in medical patients, as suggested by the excellent positive predictive value of the PRIME-MD in our study. 相似文献
115.
Nils Bomer Niels Grote Beverborg Martijn F. Hoes Koen W. Streng Mathilde Vermeer Martin M. Dokter Jan IJmker Stefan D. Anker John G.F. Cleland Hans L. Hillege Chim C. Lang Leong L. Ng Nilesh J. Samani Jasper Tromp Dirk J. van Veldhuisen Daan J. Touw Adriaan A. Voors Peter van der Meer 《European journal of heart failure》2020,22(8):1415-1423
116.
117.
118.
Christine Q Chang Ajay Yesupriya Jessica L Rowell Camilla B Pimentel Melinda Clyne Marta Gwinn Muin J Khoury Anja Wulf Sheri D Schully 《European journal of human genetics : EJHG》2014,22(3):402-408
Candidate gene and genome-wide association studies (GWAS) represent two complementary approaches to uncovering genetic contributions to common diseases. We systematically reviewed the contributions of these approaches to our knowledge of genetic associations with cancer risk by analyzing the data in the Cancer Genome-wide Association and Meta Analyses database (Cancer GAMAdb). The database catalogs studies published since January 1, 2000, by study and cancer type. In all, we found that meta-analyses and pooled analyses of candidate genes reported 349 statistically significant associations and GWAS reported 269, for a total of 577 unique associations. Only 41 (7.1%) associations were reported in both candidate gene meta-analyses and GWAS, usually with similar effect sizes. When considering only noteworthy associations (defined as those with false-positive report probabilities ≤0.2) and accounting for indirect overlap, we found 202 associations, with 27 of those appearing in both meta-analyses and GWAS. Our findings suggest that meta-analyses of well-conducted candidate gene studies may continue to add to our understanding of the genetic associations in the post-GWAS era. 相似文献
119.
Jesús Sotomayor-Bonilla Andrea Chaves Oscar Rico-Chávez Melinda K. Rostal Rafael Ojeda-Flores Mónica Salas-Rojas álvaro Aguilar-Setien Sergio Ibá?ez-Bernal Arturo Barbachano-Guerrero Gustavo Gutiérrez-Espeleta J. Leopoldo Aguilar-Faisal A. Alonso Aguirre Peter Daszak Gerardo Suzán 《The American journal of tropical medicine and hygiene》2014,91(1):129-131
120.
Martin Miner Ajay Nehra Graham Jackson Shalender Bhasin Kevin Billups Arthur L. Burnett Jacques Buvat Culley Carson Glenn Cunningham Peter Ganz Irwin Goldstein Andre Guay Geoff Hackett Robert A. Kloner John B. Kostis K. Elizabeth LaFlamme Piero Montorsi Melinda Ramsey Raymond Rosen Richard Sadovsky Allen Seftel Ridwan Shabsigh Charalambos Vlachopoulos Frederick Wu 《The American journal of medicine》2014
An association between erectile dysfunction and cardiovascular disease has long been recognized, and studies suggest that erectile dysfunction is an independent marker of cardiovascular disease risk. Therefore, assessment and management of erectile dysfunction may help identify and reduce the risk of future cardiovascular events, particularly in younger men. The initial erectile dysfunction evaluation should distinguish between predominantly vasculogenic erectile dysfunction and erectile dysfunction of other etiologies. For men believed to have predominantly vasculogenic erectile dysfunction, we recommend that initial cardiovascular risk stratification be based on the Framingham Risk Score. Management of men with erectile dysfunction who are at low risk for cardiovascular disease should focus on risk-factor control; men at high risk, including those with cardiovascular symptoms, should be referred to a cardiologist. Intermediate-risk men should undergo noninvasive evaluation for subclinical atherosclerosis. A growing body of evidence supports the use of emerging prognostic markers to further understand cardiovascular risk in men with erectile dysfunction, but few markers have been prospectively evaluated in this population. In conclusion, we support cardiovascular risk stratification and risk-factor management in all men with vasculogenic erectile dysfunction. 相似文献